SQN Clinical had a successful two days at Outsourcing in Clinical Trials UK & Ireland 2019 at the AMBA Hotel London.
Topics ranging from Brexit, sponsor oversight, patient-centric, harnessing the best practices for monitoring clinical trials to align with ICH-GCP expectations, effective CRO management strategies to recognising CRO partnerships from the perspective of a small biotech’.
John Shillingford, Director of Clinical Research, Afon Technology paid a lovely tribute to Tony Rees at the conference, the former Executive Director of SQN Clinical (Syne qua non Ltd), who sadly past away at the beginning of the year, a major character in the industry, who will be greatly missed.
The SQN Clinical stand was as popular as ever, not just because SQN is one of the worlds recognised specialist clinical biometrics CRO’s but also because of the fantastic chocolates that Karen Grover, SQN Company Director and Lester Powell, Business Development Manager, were shared to all that came by.
Thank you to all those that enjoyed the chocolates and insights in how SQN Clinical can save you time, money and peace of mind in your data management, CRF design, ePRO, and much more. We hope to see you again very soon.
HIGH QUALITY, LOW RISK AND TRUST…IS SIMPLY A CHOICE
SQN is one of the worlds recognised specialist clinical biometrics CROs supporting global pharma, biotech, medical device and animal health partners with innovative, cost effective clinical development services.
You will undoubtedly have already engaged with the relevant authorities and had those concept discussions throughout your development and late phase studies. Now with confidence high and the pivotal studies...
The delivery of the statistical analysis for any project within the pharmaceutical/R&D industry is paramount to the success of the project and the respective development targets. It is without doubt...